U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. 2024 FDA Oncology Center of Excellence Pediatric Advocacy Forum - 10/15/2024
  1. FDA Meetings, Conferences and Workshops

Forum | Mixed

Event Title
2024 FDA Oncology Center of Excellence Pediatric Advocacy Forum
October 15, 2024

Scheduled
Date:
October 15, 2024
Time:
9:00 a.m. - 1:00 p.m. ET
Organized By:
Organizer
2024 FDA Oncology Center of Excellence Pediatric Advocacy Forum

Attend In-person and Virtual

In-person: Registration will close on October 7, 2024
Register for In-person here

FDA White Oak Campus
Building 31
White Oak Great Room
10903 New Hampshire Avenue
Silver Spring, Maryland

*In-person attendees are invited to arrive at 8:30am for coffee prior to the start of the event.

Virtual: Registration will remain open through the event
Register for Virtual here

Link to be provided upon registration via confirmation email.

Background

The FDA Oncology Center of Excellence (OCE) Pediatric Oncology Program cordially invites members of the pediatric oncology advocacy community to participate in this forum to strengthen collaboration and promote more efficient development of new safe and effective drugs and biological products for pediatric patients with cancer. This forum will feature brief presentations by FDA scientists on topics of interest to the community, followed by informal discussion. Time will also be dedicated to a listening session for advocacy members to provide perspectives on topics of their choice, as well as networking for those who attend in person.

Event Goals

This forum provides an opportunity for informal dialogue between FDA staff involved in overseeing development of new products to treat pediatric cancers and patient advocates, and aims to achieve the following goals:

  1. Foster an improved understanding of the priorities and perspectives of the pediatric cancer advocacy community.
  2. Increase awareness of OCE Pediatric Oncology Program efforts and programs to promote pediatric cancer drug development.
  3. Identify potential future collaborations between the OCE Pediatric Oncology Program and the pediatric cancer advocacy community.

Materials

Contacts

Erica Horodniceanu, MPH
Senior Health Scientist
Oncology Center of Excellence, (OCE)
Office of the Commissioner (OC)
U.S. Food and Drug Administration
Erica.Horodniceanu@fda.hhs.gov

Christine Lincoln, BSN, RN, MS, MBA
Supervisory Health Scientist
Oncology Center of Excellence, (OCE)
Office of the Commissioner (OC)
U.S. Food and Drug Administration
christine.lincoln@fda.hhs.gov

Event Materials

Title File Type/Size
Agenda for the Pediatric Advocacy Forum 10.15.2024 pdf (137.11 KB)
Biographies for the Pediatric Advocacy Forum 10.15.2024 pdf (179.27 KB)
Back to Top